ReviewFrontiers in pediatrics2025
What paediatricians need to know about modern urologic management of vesicoureteral reflux.
Review in Frontiers in pediatrics, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
4 citing papers in PubMed.
- Personalized Medicine in Pediatric Urology: From Diagnosis to Individualized Risk Assessment.Medical sciences (Basel, Switzerland) · 2026Review
- Hutch diverticulum revealed by intermittent inguinal mass and associated vesico-ureteral reflux in a child.Urology case reports · 2026Article
- Prevalence and Clinical Features of Vesicoureteral Reflux in Children With Recurrent Urinary Tract Infections: A Cross-Sectional Study.Health science reports · 2026Article
- Editorial: Urinary lithiasis in children.Frontiers in pediatrics · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Vesicoureteral reflux (VUR) is a common urological disorder in children, and its prevalence is difficult to determine, as many VUR cases remain asymptomatic. VUR is considered nearly physiological during infancy and often resolves spontaneously within the first few years of life. Most patients present with low-grade VUR, which is thought to be caused by an insufficient intramural course of the ureter in the bladder wall, a condition that tends to improve as the child grows and develops. The higher the grade of VUR , the lower the probability of spontaneous resolution of this condition during early childhood. Knowledge of the pathophysiology of VUR and renal scarring has evolved over the past decades. While surgical correction of VUR is thus often discussed, it is ultimately reserved for very selected cases, mainly when high-grade VUR persists despite the correction of voiding disorders in toilet-trained children and is associated with recurrent febrile UTI. European and other international pediatric urology societies have published guidelines for VUR management in children. With minimally invasive surgery becoming increasingly common among pediatric urologists, treatment modalities for VUR have evolved significantly, and endoscopic, laparoscopic, and robotic-assisted procedures now play a central role in surgical management. The recently updated ESPU/EAU guidelines are considered as a reference for pediatric urologists across Europe. In this review, we examine the recent literature and these guidelines to provide pediatricians with up-to-date data on VUR pathophysiology, its renal consequences, and current approaches to urological management.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.